Reed Thomas D. 4
4 · INTREXON CORP · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Reed Thomas D.
Chief Science Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2019-12-31+14,340→ 132,117 total - Sale
Common Stock
[F2]2020-01-02$5.60/sh−3,533$19,785→ 128,584 total - Exercise/Conversion
Restricted Stock Units
[F1][F5]2019-12-31−14,340→ 14,340 total→ Common Stock (14,340 underlying)
Holdings
- 62,840(indirect: By Trust)
Common Stock
[F3] - 41,705(indirect: By Trust)
Common Stock
[F4] - 2,440(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- [F2]This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]Held by the Thomas David Reed Living Trust dated February 4, 2011.
- [F4]Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.
- [F5]The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest on March 31, 2020.
Signature
/s/ Thomas D. Reed, by Donald P. Lehr, as attorney-in-fact|2020-01-03